首页> 外国专利> PROCESS FOR THE PURIFICATION OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST FROM RECOMBINANT E. COLI

PROCESS FOR THE PURIFICATION OF HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST FROM RECOMBINANT E. COLI

机译:从重组大肠杆菌纯化人白细胞介素-1受体拮抗剂的方法

摘要

A process for purifying human Interleukin-1 receptor antagonist (IL-1ra), obtained by fermenting a strain of recombinant E. coli, which comprises: a) loading the mixture to be purified, which has been buffered at a pH value lower than 6.2 and optionally diluted to reduce its ionic strength at a low value, onto a cationic exchange matrix and eluting said matrix with an aqueous buffered solution having a pH value from about 7.5 to 9.0 and a low ionic strength; and b) applying the eluate from the cationic exchange step, containing the desired IL-1ra protein, directly onto an anionic exchange matrix and eluting with an aqueous buffered solution having a pH value within the above range 7.5 to 9.0 and an increased ionic strength.
机译:一种通过发酵重组大肠杆菌菌株获得的纯化人白细胞介素-1受体拮抗剂(IL-1ra)的方法,该方法包括:a)加载待纯化的混合物,该混合物已在低于6.2的pH值下缓冲任选地稀释以降低其离子强度,降低其在阳离子交换基质上的浓度,并用pH值为约7.5至9.0且离子强度低的缓冲水溶液洗脱所述基质; b)将含有所需IL-1ra蛋白的阳离子交换步骤的洗脱液直接涂在阴离子交换基质上,并用pH值在7.5至9.0范围内并具有增强的离子强度的缓冲水溶液洗脱。

著录项

  • 公开/公告号IL127155B

    专利类型

  • 公开/公告日2007-05-15

    原文格式PDF

  • 申请/专利权人 GRUPPO LEPETIT S.P.A.;

    申请/专利号IL127155

  • 发明设计人

    申请日1997-05-21

  • 分类号C12N15/09;C07K1/18;C07K14/54;C12N1/21;

  • 国家 IL

  • 入库时间 2022-08-21 20:58:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号